Chief Science Officer, Poplar Healthcare
BIOGRAPHY
JAN 18, 2024 10:00 AM PST
STAYING AHEAD OF THE CHANGING HPV TESTING LANDSCAPE: A 360 DEGREE REVIEW
Speakers
-
Mark Stoler, M.D.
Professor (emeritus) of Pathology at University of Virginia Health SystemBIOGRAPHY
Event Date & Time
Date: January 18, 2024
Time: 10:00 AM (PST), 1:00 PM (EST), 7:00 PM (CET)
Abstract
In 2020, American Cancer Society released an updated cervical cancer screening guideline calling for primary human papillomavirus (HPV) screening as the preferred strategy. Utility of HPV primary screening enables risk stratification by genotyping which leads to more effective triage and personalized care for patients.This webinar will review the results from the Alinity m HR HPV clinical trial and how this test may be utilized in clinical practice.This webinar will also review the workflow efficiencies that can be achieved when introducing an automated pre-analytical system* to HPV testing.
Learning Objectives
- A review of HPV screening in the US: Current Status and Opportunities
- Overview of the Alinity m HR HPV assay performance and how extended genotyping can be used for triage of HPV positive patients
- Evaluate a real world workflow evaluation of the Alinity HR HPV and Alinity mp pre-analytical platform*
Webinars will be available for on-demand viewing for 24 months after broadcast.
*Alinity mp is under development and not commercially available in the United States
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...